The Quebec Breast Cancer Foundation and the Quebec Clinical Research Organization in Cancer (Q-CROC) are pleased to announce their new partnership to optimize support for those affected by breast cancer.
Breast cancer is the most common cancer affecting women in Canada. It is estimated that one in eight Canadian women will develop breast cancer, and one in 34 will die from it. Mortality rates from breast cancer have been falling steadily (40%) since the mid-1980s. Among other things, this reduction is due to earlier diagnosis and advances in treatment thanks to research.
“Q-CROC is pleased to collaborate with the Quebec Breast Cancer Foundation, a leading organization in the Quebec oncology environment for nearly 30 years. By working together, our two organizations will raise awareness and improve access to breast cancer clinical trials in Quebec.” – Lucie D’Amours, General Manager, Q-CROC
“Our partnership with Q-CROC will enable us to continue promoting and facilitating access to clinical research in Quebec, and its importance for those affected by breast cancer.” Cédric Baudinet, Director of Health Promotion and Investments, QBCF.
Visit the Quebec Breast Cancer Foundation website to learn more about breast cancer and the Foundation’s activities: https://rubanrose.org/
Did you know?
In Quebec, some 50 clinical trials are currently open for recruitment in Montreal, Laval, Saint-Jérôme, Longueuil, Sherbrooke, Trois-Rivières, Quebec City, Lévis, Chicoutimi and Rimouski. Over 1100 people living with breast cancer have taken part in a clinical trial in 2022. The active participation of women in clinical research will continue to support the progress made in recent years in all aspects and stages of the disease. To find out about clinical trials recruiting breast cancer participants in Quebec, visit www.oncoquebec.com.